Jazz Pharmaceuticals
JAZZ
JAZZ
470 hedge funds and large institutions have $8.3B invested in Jazz Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 167 increasing their positions, 154 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 484 → 470 (-14)
6% less capital invested
Capital invested by funds: $8.81B → $8.3B (-$509M)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
470
Holding in Top 10
5
Calls
$14.8M
Puts
$8.22M
Top Buyers
| 1 | +$112M | |
| 2 | +$105M | |
| 3 | +$70M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$47.8M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$38.4M |
Top Sellers
| 1 | -$106M | |
| 2 | -$60.6M | |
| 3 | -$60.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$52.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.2M |